[1]赵新宇,朱良付.颅内动脉粥样硬化性狭窄血管内支架成形术后支架再狭窄相关危险因素的研究进展[J].介入放射学杂志,2023,32(11):1150-1155.
　ZHAO Xinyu,ZHU Liangfu..Advances in the study of risk factors associated with in-stent restenosis after endovascular stenting for intracranial atherosclerotic stenosis[J].journal interventional radiology,2023,32(11):1150-1155.
点击复制

颅内动脉粥样硬化性狭窄血管内支架成形术后支架再狭窄相关危险因素的研究进展()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年11
页码:
1150-1155
栏目:
综述
出版日期:
2023-11-30

文章信息/Info

Title:
Advances in the study of risk factors associated with in-stent restenosis after endovascular stenting for intracranial atherosclerotic stenosis
作者:
赵新宇;  朱良付
Author(s):
ZHAO Xinyu;  ZHU Liangfu.
Department of Cerebrovascular Diseases， Henan University People’s Hospital， Zhengzhou， Henan Province 450003， China
关键词:
【关键词】 脑卒中;  颅内动脉粥样硬化;  支架内再狭窄;  危险因素
文献标志码:
A
摘要:
【摘要】 随着我国经济水平不断发展，脑卒中患病率明显上升，已跃居世界首位，且远高于欧美等发达国家。有研究显示，在亚洲由颅内动脉粥样硬化性狭窄（intracranial atherosclerotic stenosis，ICAS）所导致的脑卒中已经高达30%～50%，且有继续增高的趋势，与血管内治疗相伴的支架内再狭窄（in- stent restenosis，ISR）问题也越来越受到关注。既往研究显示，支架种类、病变血管性质、患者高危因素、患者体内相关因子水平及基因、术后药物使用等因素都可影响ISR的发生。本文拟对颅内血管ISR的危险因素进行综述。

参考文献/References:

［1］ Pu Y， Liu L， Wang Y， et al. Geographic and sex difference in the distribution of intracranial atherosclerosis in China［J］. Stroke， 2013， 44： 2109- 2114.
［2］ Nicolais C， Lakhter V， Virk HUH， et al. Therapeutic options for in- stent restenosis［J］. Curr Cardiol Rep， 2018， 20： 7.
［3］ He J， Bao Q， Yan M， et al. The role of Hippo/yes- associated protein signalling in vascular remodelling associated with cardiovascular disease［J］. Br J Pharmacol， 2018， 175： 1354- 1361.
［4］ Mehran R， Dangas G， Abizaid AS， et al. Angiographic patterns of in- stent restenosis： classification and implications for long- term outcome［J］. Circulation， 1999， 100： 1872- 1878.
［5］ Albuquerque FC， Levy EI， Turk AS， et al. Angiographic patterns of Wingspan in- stent restenosis［J］. Neurosurgery， 2009， 63： 23- 27.
［6］ Wang J， Yuan S， Qi J， et al. Advantages and prospects of optical coherence tomography in interventional therapy of coronary heart disease（Review）［J］. Exp Ther Med， 2022， 23： 255.
［7］ Shin YS，Kim BM，Suh SH， et al. Wingspan stenting for intracranial atherosclerotic stenosis： clinical outcomes and risk factors for in- stent restenosis［J］. Neurosurgery， 2013， 72： 596- 604.
［8］ Jiang WJ， Yu W， Du B， et al. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting［J］. Stroke， 2011， 42： 1971- 1975.
［9］ Kang K， Gao F， Mo D， et al. Outcome of endovascular recana- lization for intracranial in- stent restenosis［J］. J Neurointerv Surg， 2020， 12： 1094- 1098.
［10］ Jin M， Fu X， Wei Y， et al. Higher risk of recurrent ischemic events in patients with intracranial in- stent restenosis［J］. Stroke， 2013， 44： 2990- 2994.
［11］ Alexander MJ， Zauner A， Gupta R， et al. The WOVEN trial： Wingspan one- year vascular events and neurologic outcomes［J］. J Neurointerv Surg， 2021， 13： 307- 310.
［12］ Kang K， Zhang Y， Shuai J， et al. Balloon- mounted stenting for ICAS in a multicenter registry study in China： a comparison with the WEAVE/WOVEN trial［J］. J Neurointerv Surg， 2021， 13： 894- 899.
［13］ Ueda T， Takaishi S， Yoshie T， et al. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis［J］. BMC Neurol， 2022， 22： 477.
［14］ Abdollahifard S， Yousefi O， Kamran H， et al. Balloon- mounting stent for intracranial arterial stenosis： a comprehensive and comparative systematic review and meta- analysis［J］. Interv Neuroradiol， 2023， 29：466- 480.
［15］ 项以力，张温凯，杨 镛． 药物涂层球囊和无涂层球囊治疗股腘动脉缺血性疾病疗效及安全性meta分析［J］． 介入放射学杂志， 2017， 26：500- 507．
［16］ Gruber P， Garcia- Esperon C， Berberat J， et al. Neuro elutax SV drug- eluting balloon versus wingspan stent system in symptomatic intracranial high- grade stenosis： a single- center experience［J］. J Neurointerv Surg， 2018， 10： e32.
［17］ Han J， Zhang J， Zhang X， et al. Drug- coated balloons for the treatment of symptomatic intracranial atherosclerosis： initial experience and follow- up outcome［J］. J Neurointerv Surg， 2019， 11： 569- 573.
［18］ Zhang J， Zhang X， Zhang J， et al. Drug- coated balloon dilation compared with conventional stenting angioplasty for intracranial atherosclerotic disease［J］. Neurosurgery， 2020， 87： 992- 998.
［19］ Jia B， Zhang X， Ma N， et al. Comparison of drug- eluting stent with bare- metal stent in patients with symptomatic high- grade intracranial atherosclerotic stenosis： a randomized clinical trial［J］. JAMA Neurol， 2022， 79： 176- 184.
［20］ Qiao H， Chang C， Wang AY， et al. Safety and efficacy of drug coated balloon angioplasty for intracranial atherosclerotic disease［J］. J Neurointerv Surg， 2022： neurintsurg- neurint2022.
［21］ Megaly M， Alani F， Cheng CI， et al. Risk factors for the development of carotid artery in- stent restenosis： multivariable analysis［J］. Cardiovasc Revasc Med， 2021， 24： 65- 69.
［22］ Takao N， Hagiwara Y， Shimizu T， et al. Preprocedural carotid plaque echolucency as a predictor of in- stent intimal restenosis after carotid artery stenting［J］. J Stroke Cerebrovasc Dis， 2020， 29： 105339.
［23］ Guo X， Ma N， Gao F， et al. Long- term risk factors for intracranial in- stent restenosis from a multicenter trial of stenting for symptomatic intracranial artery stenosis registry in China［J］. Front Neurol， 2020， 11： 601199.
［24］ Yang K， Fang S， Zhang X， et al. In- stent restenosis after vertebral artery origin stenosis stenting： a nomogram for risk assessment［J］. J Neurointerv Surg， 2023，15：e41- e45.
［25］ Zhang K， Li TX， Wang ZL， et al. Factors affecting in- stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases［J］. Sci Rep， 2021， 11： 10479.
［26］ Peng G， Zhang Y， Miao Z. Incidence and risk factors of in- stent restenosis for symptomatic intracranial atherosclerotic stenosis： a systematic review and meta- analysis［J］. AJNR Am J Neuroradiol， 2020， 41： 1447- 1452.
［27］ Zu M， Xu H， Gu Y， et al. The application and efficacy of stent place for Budd- Chiari syndrome［J］. J Interv Med， 2018， 1： 170- 175.
［28］ Wu ZH，Qiu HC，Hu SS，et al. Interventional treatment of symp- tomatic intracranial in- stent restenosis［J］. Zhonghua Yi Xue Za Zhi， 2018， 98： 3017- 3020.
［29］ Fiorella DJ， Levy EI， Turk AS， et al. Target lesion revascu- larization after wingspan： assessment of safety and durability［J］. Stroke， 2009， 40： 106- 110.
［30］ Zhang X， Zhou Y， Ding W， et al. TPO- Ab plays a role in arterial remodeling in patients with intracranial stenosis［J］. Atherosclerosis， 2019， 280： 140- 146.
［31］ 苗修前，张丹凤，张卫东． 大脑中动脉粥样硬化性狭窄患者血流动力学与血管重构的相关性［J］． 国际脑血管病杂志， 2020，28：821- 826．
［32］ Guo R， Zhang X， Zhu X， et al. Morphologic characteristics of severe basilar artery atherosclerotic stenosis on 3D high- resolution MRI［J］. BMC Neurol， 2018， 18： 206.
［33］ Yang WJ，Wasserman BA，Zheng L，et al. Understanding the clinical implications of intracranial arterial calcification using brain CT and vessel wall imaging［J］. Front Neurol， 2021， 12： 619233.
［34］ Xu R， Yang B， Li L， et al. Macrocalcification of intracranial vertebral artery may be related to in- stent restenosis： lessons learned from optical coherence tomography［J］. J Neurointerv Surg， 2022， 14： neurintsurg- 2021- 017913.
［35］ Jiang S， Liu Q， Zhang C， et al. High- resolution vessel wall MRI in assessing postoperative restenosis of intracranial atherosclerotic disease before drug- coated balloon treatment： an outcome prediction study［J］. J Magn Reson Imaging， 2023，58：69- 78.
［36］ Tokunaga K， Tokunaga S， Hara K， et al. Intraplaque high- intensity signal on time- of- flight magnetic resonance angiography and restenosis after carotid artery stenting［J］. J Neurosurg， 2022， 136： 1029- 1034.
［37］ Yang H， Zhu Y， Geng Z， et al. Clinical value of black- blood high- resolution magnetic resonance imaging for intracranial atherosclerotic plaques［J］. Exp Ther Med， 2015， 10： 231- 236.
［38］ Tian B， Zhu C， Tian X， et al. Baseline vessel wall magnetic resonance imaging characteristics associated with in- stent restenosis for intracranial atherosclerotic stenosis［J］. J Neurointerv Surg， 2023， 15： 288- 291.
［39］ Guo J， Ning Y， Wu S， et al. Risk factors for in- stent restenosis after vertebral artery stenting of V1 segment： a systematic review and meta- analysis［J］. Catheter Cardiovasc Interv， 2022， 100： 279- 289.
［40］ Jakubiak GK， Pawlas N，Cieslar G， et al. Pathogenesis and clinical significance of in- stent restenosis in patients with diabetes［J］. Int J Environ Res Public Health， 2021， 18： 11970.
［41］ Zheng D， Mingyue Z， Wei S， et al. The incidence and risk factors of in- stent restenosis for vertebrobasilar artery stenting［J］. World Neurosurg， 2018， 110： e937-e941.
［42］ Vértes M， Nguyen DT， Szekely G， et al. Middle and distal common carotid artery stenting： long- term patency rates and risk factors for in- stent restenosis［J］. Cardiovasc Intervent Radiol， 2020， 43： 1134- 1142.
［43］ Kang Z，Cao Y，Li L，et al. The association between apolipop- rotein E gene polymorphism and in- stent restenosis after extracranial and intracranial artery stenting［J］. J Stroke Cerebrovasc Dis， 2021， 30： 105424.
［44］ 何 钰，王建波，王 武． 颅内动脉粥样硬化性狭窄支架植入术后再狭窄机制及治疗新进展［J］． 介入放射学杂志， 2021， 30：1184- 1189．
［45］ Gao XF， Wang ZM， Chen AQ， et al. Plasma small extracellular Vesicle- Carried miRNA- 501- 5p promotes vascular smooth muscle cell phenotypic modulation- mediated in- stent restenosis［J］. Oxid Med Cell Longev， 2021， 2021： 6644970.
［46］ Yu Y， Yan L， Lou Y， et al. Multiple predictors of in- stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis［J］. J Neurosurg，2021，136：1716- 1725.
［47］ Zhang H， Yan QF， Shen H， et al. Recurrent in- stent thrombosis following V4 segment of vertebral artery stenting： a case report［J］. Int J Surg Case Rep， 2021，85： 106288.

相似文献/References:

[1]李贵福,马朝晖,罗望池,等.Solitaire AB型支架用于急性脑动脉闭塞取栓术31例[J].介入放射学杂志,2012,(02):98.
　LI Gui-fu,MA Zhao-hui,LUO Wang-chi,et al.The use of Solitaire AB stent in mechanical thrombectomy for acute cerebral artery occlusion: the initial experience in 31 cases[J].journal interventional radiology,2012,(11):98.
[2]刘永晟,王 峰,李 克,等. MO.MA球囊保护下近闭塞颈动脉支架成形术的临床研究[J].介入放射学杂志,2012,(06):447.
　LIU Yong- sheng,WANG Feng,LI Ke,et al. Stenting angioplasty with the help of MO.MA proximal cerebral protection device for the treatment of nearly?蛳occluded carotid artery: a clinical study[J].journal interventional radiology,2012,(11):447.
[3]张 冰,王亚仙,茹立新,等. 椎-基底动脉夹层的诊断和治疗策略选择[J].介入放射学杂志,2013,(05):358.
　ZHANG Bing,WANG Ya? xian,RU Li? xin,et al. The diagnosis and therapeutic strategy of vertebobasilar artery dissection[J].journal interventional radiology,2013,(11):358.
[4]郭新宾,陈 振,王子博,等. 急诊血管成形及支架植入术治疗急性 大脑中动脉闭塞[J].介入放射学杂志,2012,(10):802.
　GUO Xin- bin,CHEN Zhen,WANG Zi- bo,et al. Emergency angioplasty and stent placement for the treatment of acute middle cerebral artery occlusion[J].journal interventional radiology,2012,(11):802.
[5]邵秋季,朱良付,李天晓. 急性重型缺血性脑卒中支架型取栓装置的研究进展[J].介入放射学杂志,2013,(09):786.
　SHAO Qiu? ji,ZHU Liang? fu,LI Tian? xiao.. Research progress of stent retriever in treatment of acute severe ischemic stroke[J].journal interventional radiology,2013,(11):786.
[6]徐 瑞,殷世武,王 转,等.支架取栓与动脉溶栓治疗急性缺血性脑卒中比较[J].介入放射学杂志,2016,(12):1027.
　XU Rui,YIN Shi- wu,WANG Zhuan,et al.The treatment of acute ischemic stroke： comparison between stent- retrieval thrombectomy and intra- arterial thrombolysis [J].journal interventional radiology,2016,(11):1027.
[7]董 韬,万 乐,曲国辉,等.急性缺血性脑卒中出血转化后再梗死行机械取栓2例[J].介入放射学杂志,2020,29(09):875.
　DONG Tao,WAN Le,QU Guohui,et al.Mechanical thrombectomy for cerebral re-infarction in patients with acute ischemic stroke after hemorrhagic transformation： report of two cases[J].journal interventional radiology,2020,29(11):875.
[8]雷毅,管文婷,冷硕,等.急性后循环缺血机械取栓研究现状与进展[J].介入放射学杂志,2020,29(02):210.
　LEI Yi,GUAN Wenting,LENG Shuo,et al.Mechanical thrombectomy for acute posterior circulation ischemia: research status and progress?[J].journal interventional radiology,2020,29(11):210.
[9]张桂芳,刘真亚,朱新兰,等.思维导图联合微视频健康教育对脑卒中合并房颤患者遵医行为的效果评价 [J].介入放射学杂志,2022,31(05):503.
　ZHANG Guifang,LIU Zhenya,ZHU Xinlan,et al.Effect of mind mapping combined with micro-video health education on the compliance behavior of patients with stroke complicated by atrial fibrillation [J].journal interventional radiology,2022,31(11):503.

备注/Memo

备注/Memo:
（收稿日期：2022- 09- 04）
（本文编辑：新 宇）
更新日期/Last Update: 2023-11-30